Boulder, CO, United States of America

Sam Saccomano

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Editas Medicine, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sam Saccomano: Innovator in Synthetic Guide Molecules

Introduction

Sam Saccomano is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of chemical synthesis, particularly in the development of synthetic guide molecules. His innovative work has implications for various applications in biotechnology and medicine.

Latest Patents

Sam Saccomano holds a patent for "Synthetic guide molecules, compositions and methods relating thereto." This patent details chemical syntheses of guide molecules, along with compositions and methods related to them. The invention provides a cost-effective and straightforward chemical synthesis of high-purity unimolecular guide molecules. It minimizes the presence of n−1 and/or n+1 species, truncation species, and other contaminants. The methods involve cross-linking two or more pre-annealed guide fragments, showcasing his expertise in the field.

Career Highlights

Sam is currently employed at Editas Medicine, Inc., where he continues to push the boundaries of innovation in genetic research and therapies. His work at Editas Medicine has positioned him as a key player in the advancement of genetic engineering technologies.

Collaborations

Some of his notable coworkers include Stacy Capehart and Bruce Eaton. Their collaborative efforts contribute to the innovative environment at Editas Medicine, fostering advancements in the field.

Conclusion

Sam Saccomano's contributions to synthetic guide molecules exemplify the intersection of innovation and practical application in biotechnology. His work not only enhances our understanding of chemical syntheses but also paves the way for future advancements in genetic research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…